Help spread the word of our new journal by forwarding this mailing on to fellow researchers!

StemJournal | Welcome to Our New Board Members

Dear Colleague,

Our journal's key priority is to publish top quality stem cell research and, on that point, we are very pleased to announce that StemJournal's latest article has been published – more details available below.

We also have recently welcomed two new Editorial Board members to the senior team. Our new Senior Editor is Fredrik Lanner, PhD, from the Karolinska Institute in Stockholm, and our new Associate Editor is Meritxell Huch, PhD, from the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden. Read below to discover more about our new colleagues, along with details about other news and recent posts on the website.

Looking forward to working with you.

Kind regards,
Editors-in-Chief

Meet the Editorial Board

New Open Access Content!

Prospects for Stem Cell-Based Regenerative Therapies in India

Boopalan, Dinesh | Pandian, Ramanan | Kesavan, Gokul

The current status of stem cell therapy trials in India is assessed in this study. Recent breakthroughs in gene editing technologies, combined with stem cell therapy, can be effectively harnessed to devise large-scale and affordable treatments for haematological diseases that are highly prevalent in the country. Innovations in stem cell therapy in India can make treatments more affordable to address the needs of in-country patients. Read Article

View All Content

Our aim is for the journal's website – stemjnl.org – to become a vital portal for the stem cell community. Keep checking the site to discover all the news items that we are posting. Listed below are the latest news items from the website, listed in publication order (with the most recent at the top).

Introducing StemJournal Associate Editor: Meritxell Huch, PhD
Dr. Huch is currently a Lise Meitner Max Planck Research Group Leader at the Max Planck Institute and in this post she shares details about the research being undertaken in her lab. Read Post

STJ 2021.05.05 hidenori-q-and-a small-visual

Xenobiotic Metabolism of Intestinal Organoids: Author Q&A
Dr. Akutsu spoke with us about the new organoid model as featured in his recent StemJournal article. Discover how it may impact the drug delivery and metabolism process in our gut. Read Post

Introducing StemJournal Senior Editor: Fredrik Lanner, PhD
Dr. Lanner's research focuses on early human developmental, creating cell types for novel cell therapy strategies, and looking at how totipotency, pluripotency, and first lineage specifications are regulated in the human embryo. Read Post

Gender Balance in the StemJournal Editorial Board
Looking at the Senior Editor and Associate Editor positions of our editorial board, we have a 50:50 split between the number of men and women contributing their time and dedication to help build our journal. Read Post

Related: StemJournal's gender balance in the senior team gets featured in the IOS Press Labs blog post here.

Submit Your Stem Cell Research Here!

StemJournal publishes original, peer-reviewed content covering a wide range of topics related to stem cell research. More details here.

Why submit to our open access stem cell journal?

The many benefits for contributing authors include:
• First class Editorial Board (see here)
• Hassle free submission process via Editorial Manager (see here)
• Rigorous peer review and speedy manuscript processing
• Rapid online publication (pre-press)
• Significantly reduced article processing charge for papers accepted in 2021.

As an additional benefit, authors of accepted papers are invited to join the StemJournal Editorial Advisory Board. Read more here.

If you have specific questions about preparing your manuscript for submission, please get in touch by mail: stemjournal@iospress.com.

Sign Ups & Social Media

If you know of any colleagues or fellow researchers who are not yet signed up to receive the newsletter, we invite you to share this mailing with them. Click on the sign-up link at the bottom of this email or access here.

Did you know, StemJournal (STJ) also has a social media presence? Why not take the time today to follow us on Twitter?

Be part of the discussion!

You are receiving this mailing as you are signed up to receive news from STJ.
You can unsubscibe or alter your preferences at any time by clicking the links below.

StemJournal | Welcome to Our New Board Members

New Open Access Content!

Prospects for Stem Cell-Based Regenerative Therapies in India

Related: StemJournal's gender balance in the senior team gets featured in the IOS Press Labs blog post here.

Submit Your Stem Cell Research Here!

Sign Ups & Social Media

Share on Facebook

Share on Twitter

Share on Google+

Pin to Pinterest

Share on LinkedIn